Lipe & Dalton’s Brookfield Asset Management BAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Sell
40,091
-4,713
-11% -$223K 0.84% 39
2026
Q1
$1.99M Buy
44,804
+213
+0.5% +$10.4K 1.04% 34
2025
Q4
$2.34M Sell
44,591
-1,414
-3% -$76K 1.15% 30
2025
Q3
$2.62M Sell
46,005
-2,010
-4% -$120K 1.3% 28
2025
Q2
$2.65M Sell
48,015
-476
-1% -$25.6K 1.43% 24
2025
Q1
$2.35M Sell
48,491
-1,287
-3% -$70.2K 1.31% 28
2024
Q4
$2.7M Sell
49,778
-366
-0.7% -$19.8K 1.43% 24
2024
Q3
$2.37M Buy
50,144
+300
+0.6% +$12.6K 1.2% 32
2024
Q2
$1.9M Sell
49,844
-779
-2% -$30.6K 1.02% 37
2024
Q1
$2.13M Hold
50,623
1.1% 35
2023
Q4
$2.03M Sell
50,623
-300
-0.6% -$10.1K 1.1% 34
2023
Q3
$1.7M Sell
50,923
-69
-0.1% -$2.33K 1.02% 34
2023
Q2
$1.66M Sell
50,992
-948
-2% -$30.5K 0.95% 37
2023
Q1
$1.7M Buy
51,940
+17,898
+53% +$581K 0.97% 33
2022
Q4
$976K Buy
+34,042
New +$1.02M 0.56% 47

Other funds holding BAM

Lipe & Dalton's BAM Position: Q2 2026 in Review

Lipe & Dalton reduced its Brookfield Asset Management (BAM) stake by 11% in Q2 2026, selling an estimated $223K and leaving 40,091 shares worth $1.8M. The position accounts for 0.84% of the portfolio, ranked #39.

Lipe & Dalton first reported a position in BAM in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.7M in Q4 2024. 619 funds tracked by Wall St. Rank hold BAM as of Q2 2026.

  • Lipe & Dalton held 40,091 shares of Brookfield Asset Management worth $1.8M as of Q2 2026.
  • Lipe & Dalton sold 4,713 Brookfield Asset Management shares in Q2 2026, an estimated $223K.
  • Brookfield Asset Management made up 0.84% of Lipe & Dalton's portfolio in Q2 2026, its #39 holding.
  • Lipe & Dalton first reported a position in Brookfield Asset Management in Q4 2022 and has held it in 15 quarters since.
  • Lipe & Dalton's Brookfield Asset Management position peaked at $2.7M in Q4 2024.
  • 619 funds tracked by Wall St. Rank held Brookfield Asset Management as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.